Extended dosing interval reduces risk of natalizumab-related PML Clinical study 28 September 2019 Pages: 9 - 9
Fluoroquinolones: risk of aortic and mitral regurgitation Clinical study 28 September 2019 Pages: 10 - 10
Guillain-Barré syndrome following influenza vaccination Clinical study 28 September 2019 Pages: 11 - 11